Oppenheimer & Co »

Zentalis Pharmaceuticals shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $61k 13k 4.85

More positions owned by Oppenheimer & Co

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)
Marvell Technology (MRVL)

View all positions for Oppenheimer & Co

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
BlackRock
Two Sigma Investments
Vanguard Capital Management
Acadian Asset Management
Citadel Advisors
Renaissance Technologies
Opaleye Management
OrbiMed Advisors
Decheng Capital
Geode Capital Management
Bank of America Corporation
PRIMECAP Management Company
Pfizer

View all funds holding Zentalis Pharmaceuticals